Get Live Data

The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

  2. Share Prices
  3. Astrazeneca Share Price
  4. Astrazeneca Share Regulatory News

Pin to quick picksAstrazeneca Regulatory News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,988.00
Bid: 12,016.00
Ask: 12,020.00
Change: -38.00 (-0.32%)
Spread: 4.00 (0.033%)
Open: 12,070.00
High: 12,144.00
Low: 11,882.00
Prev. Close: 12,026.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

12345678910
Date   Source Headline
15th Sep 20233:00 pmRNSEnhertu recommended in EU for HER2-mutant NSCLC
11th Sep 20234:00 pmRNSFasenra Phase III EGPA trial met primary endpoint
6th Sep 20237:00 amRNSUpdate on US review of Ultomiris for NMOSD
1st Sep 20233:00 pmRNSTotal Voting Rights
1st Aug 20233:00 pmRNSTotal Voting Rights
28th Jul 20237:05 amRNSAlexion enters gene therapy agreement with Pfizer
28th Jul 20237:00 amRNSHalf-year Report
17th Jul 20236:10 pmRNSBeyfortus approved in US for infant RSV prevention
3rd Jul 20233:00 pmRNSTotal Voting Rights
3rd Jul 20237:00 amRNSDato-DXd significantly improved PFS in lung cancer
9th Jun 20237:05 amRNSnirsevimab recommended for infant RSV protection
9th Jun 20237:00 amRNSAstraZeneca agreement with Quell Therapeutics
2nd Jun 20235:00 pmRNSImfinzi improved pCR in gastric and GEJ cancers
1st Jun 20233:05 pmRNSBlock listing Interim Review
1st Jun 20233:00 pmRNSTotal Voting Rights
1st Jun 20237:00 amRNSLynparza approved in US for BRCAm prostate cancer
26th May 20237:00 amRNSImfinzi + Lynparza prolonged PFS in endometrial ca
22nd May 20237:05 amRNSDirectorate Change
17th May 20237:00 amRNSTagrisso plus chemo improved PFS in lung cancer
9th May 202311:00 amRNSDirector/PDMR Shareholding
9th May 20237:00 amRNSFarxiga extended in the US for heart failure
2nd May 20233:00 pmRNSTotal Voting Rights
2nd May 202310:00 amRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSODAC vote on Lynparza combo in prostate cancer
27th Apr 20235:30 pmRNSResult of AGM
27th Apr 20237:05 amRNSBoard Committee Changes
27th Apr 20237:00 amRNS1st Quarter Results
26th Apr 20234:45 pmRNSDirector Declaration
11th Apr 20237:00 amRNSUpdate to arrangements with Sobi and Sanofi
5th Apr 20237:00 amRNSLynparza + Imfinzi met endpoint in ovarian cancer
3rd Apr 20233:00 pmRNSTotal Voting Rights
3rd Apr 20237:00 amRNSUltomiris recommended for NMOSD EU approval
30th Mar 20237:00 amRNSAstraZeneca completes KYM agreement for CMG901
27th Mar 202311:00 amRNSDirector/PDMR Shareholding
22nd Mar 202311:00 amRNSNotice of AGM
9th Mar 20237:00 amRNSImfinzi improved EFS in resectable lung cancer
8th Mar 202311:01 amRNSDirector/PDMR Shareholding
8th Mar 202311:00 amRNSDirector/PDMR Shareholding
6th Mar 20237:00 amRNSEnhertu DESTINY-PanTumor02 shows positive results
1st Mar 20233:00 pmRNSTotal Voting Rights
1st Mar 20237:00 amRNSAstraZeneca prices a $2.25bn bond offering
24th Feb 20236:15 pmRNSAstraZeneca prices a EUR1.5bn bond offering
24th Feb 20232:05 pmRNSAstraZeneca acquires CinCor for cardiorenal asset
24th Feb 202311:00 amRNSDirector/PDMR Shareholding
23rd Feb 20237:00 amRNSAstraZeneca enters agreement with KYM for CMG901
22nd Feb 20237:10 amRNSFiling of Form 20-F with SEC
21st Feb 202311:00 amRNSAnnual Financial Report
13th Feb 20232:01 pmRNSDirector/PDMR Shareholding
13th Feb 20232:00 pmRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSFinal Results
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.